High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: A pilot study

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Dreilich, Martin ^a   Bergqvist, Michael ^a   Moberg, Martin ^b   Brattström, Daniel ^a   Gustavsson, Inger ^b   Bergström, Stefan ^a   Wanders, Alkwin ^b   Hesselius, Patrick ^a   Wagenius, Gunnar ^a   Gyllensten, Ulf ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; PORPHOBILINOGEN DEAMINASE;

ADULT; AGED; ALCOHOLISM; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PALLIATIVE THERAPY; PILOT STUDY; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SAMPLING; SURVIVAL RATE; SWEDEN; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

AGED; CARCINOMA; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 33744934750     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-94     Document Type: Article

References (25)

1. Syrjanen KJ: HPV infections and oesophageal cancer. J Clin Pathol 2002, 55(10):721-728.
2. Shen ZY, Hu SP, Lu LC, Tang CZ, Kuang ZS, Zhong SP, Zeng Y: Detection of human papillomavirus in esophageal carcinoma. J Med Virol 2002, 68(3):412-416.
3. Munoz N: Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000, 19(1-2):1-5.
4. Sandvik AK, Aase S, Kveberg KH, Dalen A, Folvik M, Naess O: Papillomatosis of the esophagus. J Clin Gastroenterol 1996, 22(1):35-37.
5. Shen ZY, Cen S, Xu LY, Cai WJ, Chen MH, Shen J, Zeng Y: E6/E7 genes of human papilloma virus type 18 induced immortalization of human fetal esophageal epithelium. Oncol Rep 2003, 10(5):1431-1436.
6. Syrjanen S: HPV infections and tonsillar carcinoma. J Clin Pathol 2004, 57(5):449-455.
7. Harima Y, Sawada S, Nagata K, Sougawa M, Ohnishi T: Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2002, 52(5):1345-1351.
8. Wu GS, Ding Z: Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line. Oncogene 2002, 21(1):1-8.
9. Kamradt MC, Mohideen N, Krueger E, Walter S, Vaughan AT: Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7. Br J Cancer 2000, 82(10):1709-1716.
10. Kim CJ, Um SJ, Hwang ES, Park SN, Kim SJ, Namkoong SE, Park JS: The antibody response to HPV proteins and the genomic state of HPVs in patients with cervical cancer. Int J Gynecol Cancer 1999, 9(1):1-11.
11. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2(5):342-350.
12. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5(6):649-655.
13. Moberg M, Gustavsson I, Gyllensten U: Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003, 41(7):3221-8.
14. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, et al.: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 344(15):1125-1131.
15. Roka S, Rasoul-Rockenschaub S, Roka J, Kirnbauer R, Muhlbacher F, Salat A: Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int 2004, 17(7):366-369.
16. Syrjanen KJ: HPV infections and lung cancer. J Clin Pathol 2002, 55(12):885-891.
17. Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY: Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 2002, 76(1):41-47.
18. Si HX, Tsao SW, Poon CS, Wang LD, Wong YC, Cheung AL: Viral load of HPV in esophageal squamous cell carcinoma. Int J Cancer 2003, 103(4):496-500.
19. Weston AC, Prolla JC: Association between esophageal squamous cell carcinoma and human papillomavirus detected by Hybrid Capture II assay. Dis Esophagus 2003, 16(3):224-228.
20. Hippelainen M, Eskelinen M, Lipponen P, Chang F, Syrjanen K: Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus. Anticancer Res 1993, 13(3):677-681.
21. Furihata M, Ohtsuki Y, Ogoshi S, Takahashi A, Tamiya T, Ogata T: Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 1993, 54(2):226-230.
22. Lindel K, Burri P, Studer HU, Altermatt HJ, Greiner RH, Gruber G: Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment. Int J Gynecol Cancer 2005, 15(2):278-284.
23. Dahlgren L, Mellin H, Wangsa D, Heselmeyer-Haddad K, Bjornestal L, Lindholm J, Munck-Wikland E, Auer G, Ried T, Dalianis T: Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Int J Cancer 2003, 107(2):244-249.
24. Ragin CC, Reshmi SC, Gollin SM: Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 2004, 110:701-709.
25. Pestell KE, Hobbs SM, Titley JC, Kelland LR, Walton MI: Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line. Mol Pharmacol 2000, 57(3):503-511.